Clinical trial
Randomized, Double Blind, Placebo Controlled Exploratory Study To Assess the Efficacy and Safety of a Triple Combination of Ibuprofen+Mg+Ascorbic Acid for Acute Pain Treatment in Temporomandibular Join Disorder (TMJD) Patients
NCT02602483 is registered in ClinicalTrials.gov with Spherium Biomed as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized, Double Blind, Placebo Controlled Exploratory Study To Assess the Efficacy and Safety of a Triple Combination of Ibuprofen+Mg+Ascorbic Acid for Acute Pain Treatment in Temporomandibular Join Disorder (TMJD) Patients
- Lead sponsor
- Spherium Biomed
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- December 31, 2015
- Completion date
- December 31, 2016
- Enrollment
- 96 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.